Cardiac procedures & devices × cardiovascular events

TrialCardiology2014

Protective effect of metformin on myocardial injury in metabolic syndrome patients following percutaneous coronary intervention.

Jing Li et al.PubMed ↗Publisher ↗

What the trial testedrandomised · 2014

Randomised comparison

Probably reduced cardiovascular events

−75%−90% to −38%

Bigger than almost all for cardiovascular events

As reported

HR 0.25, 95% CI 0.10–0.62

One number in the abstract

the abstract, start to end

and 28.9% of controls (hazard ratio 0.25, 95% CI 0.10-0.62, log rank p =

← favours treatmentfavours comparator →
could be chance
Cardiovascular events
HR 0.250.10–0.62
MetforminCardiac procedures & devicesCardiovascular events

Cardiac procedures & devices × cardiovascular eventshelps?mixed

unlikelylikely
0.500.49 without it

Metformin × cardiovascular eventshelps?mixed

unlikelylikely
0.500.50 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

12 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24335026